Advanced search
1 file | 328.68 KB Add to list

Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials

(2015) CRITICAL CARE. 19(suppl. 1). p.S116-S117
Author
Organization

Downloads

  • 8603307.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 328.68 KB

Citation

Please use this url to cite or link to this publication:

MLA
Vande Walle, Johan et al. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-term Outcomes : a Pooled Analysis of Clinical Trials.” Critical Care. Vol. 19. 2015. S116–S117. Print.
APA
Vande Walle, J., Delmas, J., Ardissimo, G., Wang, J., Kincaid, J., & Haller, H. (2015). Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. CRITICAL CARE (Vol. 19, pp. S116–S117). Presented at the 35th International symposium on Intensive Care and Emergency Medicine.
Chicago author-date
Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-term Outcomes : a Pooled Analysis of Clinical Trials.” In Critical Care, 19:S116–S117.
Chicago author-date (all authors)
Vande Walle, Johan, J Delmas, G Ardissimo, J Wang, J Kincaid, and H Haller. 2015. “Early Initiation of Eculizumab Treatment in Patients with Atypical Haemolytic Uraemic Syndrome Improves Long-term Outcomes : a Pooled Analysis of Clinical Trials.” In Critical Care, 19:S116–S117.
Vancouver
1.
Vande Walle J, Delmas J, Ardissimo G, Wang J, Kincaid J, Haller H. Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials. CRITICAL CARE. 2015. p. S116–S117.
IEEE
[1]
J. Vande Walle, J. Delmas, G. Ardissimo, J. Wang, J. Kincaid, and H. Haller, “Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials,” in CRITICAL CARE, Brussels, Belgium, 2015, vol. 19, no. suppl. 1, pp. S116–S117.
@inproceedings{8603308,
  articleno    = {P330},
  author       = {Vande Walle, Johan and Delmas, J and Ardissimo, G and Wang, J and Kincaid, J and Haller, H},
  booktitle    = {CRITICAL CARE},
  issn         = {1466-609X},
  language     = {eng},
  location     = {Brussels, Belgium},
  number       = {suppl. 1},
  pages        = {P330:S116--P330:S117},
  title        = {Early initiation of eculizumab treatment in patients with atypical haemolytic uraemic syndrome improves long-term outcomes : a pooled analysis of clinical trials},
  url          = {http://dx.doi.org/10.1186/cc14410},
  volume       = {19},
  year         = {2015},
}

Altmetric
View in Altmetric